1. Home
  2. ALCO vs MDWD Comparison

ALCO vs MDWD Comparison

Compare ALCO & MDWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alico Inc.

ALCO

Alico Inc.

HOLD

Current Price

$41.44

Market Cap

314.2M

Sector

N/A

ML Signal

HOLD

Logo MediWound Ltd.

MDWD

MediWound Ltd.

HOLD

Current Price

$16.92

Market Cap

193.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALCO
MDWD
Founded
1960
2000
Country
United States
Israel
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
314.2M
193.3M
IPO Year
1994
2013

Fundamental Metrics

Financial Performance
Metric
ALCO
MDWD
Price
$41.44
$16.92
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$44.00
$36.00
AVG Volume (30 Days)
29.9K
81.7K
Earning Date
05-12-2026
05-20-2026
Dividend Yield
0.47%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$48.88
Revenue Next Year
N/A
$35.08
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$27.61
$14.14
52 Week High
$43.20
$22.51

Technical Indicators

Market Signals
Indicator
ALCO
MDWD
Relative Strength Index (RSI) 66.57 50.58
Support Level $39.99 $16.68
Resistance Level $42.58 $18.71
Average True Range (ATR) 1.28 0.77
MACD 0.38 -0.01
Stochastic Oscillator 99.80 70.87

Price Performance

Historical Comparison
ALCO
MDWD

About ALCO Alico Inc.

Alico Inc is a Florida-based agribusiness and land management company that mainly focuses on citrus production and grove conservation. The company operates through two primary business units: Alico Citrus and Land Management and Other Operations. The Alico Citrus segment engages in the cultivation of citrus trees and delivers citrus to the processed and fresh citrus markets. It mainly serves the processed market and sells Hamlin oranges and the Valencia variety to the orange juice processors. The Land Management and Other Operations segment engages in land leasing for recreational, conservation, and mining activities. Alico Citrus delivers the majority of the revenue as the firm's primary operating business unit.

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid, is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

Share on Social Networks: